Jane Leopold News Today

This channel includes news and new technology innovations for patient engagement.

Significant improvements in six-minute walking distance were reported in the STELLAR Phase III Trial whose findings were unveiled during a Featured Clinical Research session on the final day of the March 4-6 American College of Cardiology Scientific Session, ACC23 Together with WCC. Researchers added a novel first-in-class medication in combination with background therapy in patients with pulmonary arterial hypertension (PAH), a severe, progressive condition that affects the heart and lungs.

Worryingly, mismatch at 1 year also predicted 3-year all-cause death, spurring calls for RCTs in this setting.